Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
According to the data presented by Eli Lilly from the SURMOUNT-5 study involving 700 patients, tirzepatide resulted in 47% greater weight loss after 18 months of treatment (25 kg vs 16.5 kg) alongside a reduced-calorie diet and increased physical activity compared to semaglutide
Prabhakaran S, Ruff I, Bernstein RA
Novo Nordisk has confirmed it expects to make it available via private prescription within weeks
Patients without insurance coverage may qualify for affordable self-pay weight loss programs, including compounded tirzepatide treatment options and structured physician-guided care plans
It requires clinical trials, in-depth review of both the safety and efficacy of each drug, and continuous monitoring afterward
US$ 26.70
US$ 27.72
US$ 27.19
US$ 29.94
US$ 29.31
US$ 28.90
US$ 21.65
US$ 22.97
